Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
X4 Pharmaceuticals, Inc | Chief Medical Officer | Stock Option (right to buy) | 1.25M | Aug 31, 2023 | Direct | ||
X4 Pharmaceuticals, Inc | Chief Medical Officer | Stock Appreciation Right | 181K | Feb 13, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
XFOR | X4 Pharmaceuticals, Inc | Feb 13, 2024 | 1 | $0 | 4/A | Feb 28, 2024 | Chief Medical Officer |
XFOR | X4 Pharmaceuticals, Inc | Feb 13, 2024 | 1 | $0 | 4 | Feb 16, 2024 | Chief Medical Officer |
XFOR | X4 Pharmaceuticals, Inc | Aug 31, 2023 | 1 | $1.6M | 4 | Sep 5, 2023 | Chief Medical Officer |
XFOR | X4 Pharmaceuticals, Inc | Aug 16, 2023 | 0 | $0 | 3 | Aug 16, 2023 | Chief Medical Officer |